Safety and efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma in early clinical practice: A multicenter analysisMakoto Chuma, Shin Maeda, Tsunamasa Watanabe et al.|Hepatology Research|2021Cited by 50
Circulating microRNA‐1246 as a possible biomarker for early tumor recurrence of hepatocellular carcinomaMakoto Chuma, Naoya Sakamoto, Hidenori Toyoda et al.|Hepatology Research|2019Cited by 43
Analysis of efficacy of lenvatinib treatment in highly advanced hepatocellular carcinoma with tumor thrombus in the main trunk of the portal vein or tumor with more than 50% liver occupation: A multicenter analysisMakoto Chuma, Shin Maeda, Haruki Uojima et al.|Hepatology Research|2020Cited by 38
Contrast-enhanced ultrasonography findings using a perflubutane-based contrast agent in patients with early hepatocellular carcinomaKazushi Numata, Katsuaki Tanaka, Hiroyuki Fukuda et al.|European Journal of Radiology|2013Cited by 38
Fucosylated fraction of alpha-fetoprotein as a serological marker of early hepatocellular carcinoma.Satoshi Moriya, Katsuaki Tanaka, Manabu Morimoto et al.|PubMed|2013Cited by 25